Loading
Implicity
Implicity is a digital MedTech company founded in 2016, specializing in cardiac remote monitoring and medical research. The company offers a universal, AI-driven, cloud-based SaaS platform that aggregates data from various implantable cardiac devices. This platform is designed to enhance patient outcomes for those with implanted devices and chronic heart failure, primarily serving hospitals, clinics, Independent Diagnostic Testing Facilities (IDTFs), and cardiac electrophysiology centers. Implicity's platform automates remote monitoring by standardizing data from all major device manufacturers, reducing healthcare workload, and predicting patient health status. Key features include predictive analytics for chronic heart failure, automated ECG analysis, and tools for managing patient connectivity. With over 100,000 patients protected across more than 250 medical facilities in the U.S. and Europe, Implicity is committed to improving cardiac care delivery through innovative technology. The company is headquartered in Paris, France, with an office in Cambridge, Massachusetts.
Funding
Every round, secondary, debt facility or acquisition involving Implicity that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$28M